MGMT PROMOTER METHYLATION STATUS IN GLIOBLASTOMA (GBM) PATIENTS: A QUANTITATIVE PYROSEQUENCING APPROACH AND ITS PROGNOSTIC ROLE

著录项

• 来源
  《Neuro-Oncology》 |2017年第3期|76-76|共1页
• 作者

  Lombardi G.; Bellu L.; Bertorelle R.; Pambuku A.; Gardiman M.; Fiduccia P.; Della Puppa A.; Berti F.; DAvella D.; Zagonel V.;

  展开▼
• 作者单位

  Veneto Inst Oncol IOV IRCCS, Dept Clin & Expt Oncol, Med Oncol 1, Padua, Italy;

  Veneto Inst Oncol IOV IRCCS, Dept Clin & Expt Oncol, Med Oncol 1, Padua, Italy;

  Veneto Inst Oncol IOV IRCCS, Dept Clin & Expt Oncol, Clin Trials & Biostat Unit, Padua, Italy|Veneto Inst Oncol IOV IRCCS, Mol Immunol & Oncol Unit, Padua, Italy;

  Veneto Inst Oncol IOV IRCCS, Med Oncol, Dept Clin & Expt Oncol, Padua, Italy;

  Padua Hosp, Dept Pathol, Neurol Sci, Padua, Italy;

  Veneto Inst Oncol IOV IRCCS, Clin Trials & Biostat Unit, Padua, Italy;

  Azienda Osped Padova, Neurosurg Dept, Padua, Italy;

  Veneto Inst Oncol IOV IRCCS, Radiat Therapy Unit, Padua, Italy;

  Univ Padua, Neurosurg Dept, Padua, Italy;

  Veneto Inst Oncol IOV IRCCS, Dept Clin & Expt Oncol, Med Oncol 1, Padua, Italy;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词